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Objectives: The objectives of this study is to review the set of criteria of the Institute of
Medicine (IOM) for priority-setting in research with addition of new criteria if necessary,
and to develop and evaluate the reliability and validity of the final priority score.
Methods: Based on the evaluation of 199 research topics, forty-five experts identified
additional criteria for priority-setting, rated their relevance, and ranked and weighted them
in a three-round modified Delphi technique. A final priority score was developed and
evaluated. Internal consistency, test–retest and inter-rater reliability were assessed.
Correlation with experts’ overall qualitative topic ratings were assessed as an
approximation to validity.
Results: All seven original IOM criteria were considered relevant and two new criteria
were added (“potential for translation into practice”, and “need for knowledge”). Final ranks
and relative weights differed from those of the original IOM criteria: “research impact on
health outcomes” was considered the most important criterion (4.23), as opposed to
“burden of disease” (3.92). Cronbach’s alpha (0.75) and test–retest stability (interclass
correlation coefficient = 0.66) for the final set of criteria were acceptable. The area under
the receiver operating characteristic curve for overall assessment of priority was 0.66.
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consensus procedure. This made it possible to develop the tool without a need for further funding. The authors also express their gratitude to Cristina Jaldo´n
and Maite Solans for their administrative and technical support, and Drs. Gaieta` Permanyer and Jose´ Asu´a for reviewing previous reports of this work.
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Conclusions: A reliable instrument for prioritizing topics in clinical and health services
research has been developed. Further evaluation of its validity and impact on selecting
research topics is required.
Keywords: Health services research, Priority-setting, Research assessment
Methods that identify research gaps in health needs and that
help to set priorities for research topics can be helpful in
decision making on funding for healthcare research. Prior-
itization is usually based on the feasibility of carrying out
the research, which in turn depends on the methodological
strengths of the project and the abilities and experience of the
research team. The relevance of the research topic is presum-
ably always implicitly present in decision making on funding
for research, but it is rarely taken into account in a trans-
parent and explicit manner. Some countries (12;13;15;21)
and health technology assessment programs (1;27;31) have,
nevertheless, developed systematic prioritization methods to
optimize their investment.
Among them, the first set of criteria was developed by
the United States Institute of Medicine (IOM), which rec-
ommended seven general criteria for setting priorities for
the assessment of healthcare technologies. These criteria in-
cluded prevalence, burden of illness, cost of managing the
problem, variability in practice, potential to change health
outcomes, potential to change costs, and potential to inform
ethical, and legal or social issues (13). Several years later the
IOM Committee on Reviewing Evidence to Identify Highly
Effective Clinical Services was set to recommend an organi-
zational framework for assessing evidence on clinical effec-
tiveness so that consumers, clinicians, professional specialty
societies, payers, purchasers, and other decision makers have
independent, valid information for making healthcare deci-
sions (14). In a review of methods to prioritize topics, the
Committee concluded that no single priority setting method
was obviously superior to others and they could not find
any systematic assessments of the comparative strengths and
weaknesses of different approaches to priority setting.
Recently, the IOM Committee on Comparative Effec-
tiveness Research Prioritization was charged with recom-
mending national priorities on comparative effectiveness re-
search. The above-mentioned and other IOM previous reports
provided the initial basis for the methodology and criteria
used (21). The Committee recognized two levels of criteria
to prioritize the comparative effectiveness research topics:
(i) condition-level criteria (prevalence, mortality, morbidity,
cost, and variability), and (ii) priority topic-level criteria (util-
ity for decision making, risk associated with care, informa-
tion gaps and duplication, and gaps in translation).
In the IOM and other research priority setting meth-
ods, burden of disease, variability in clinical practice, and
the cost-effectiveness of healthcare interventions are among
the most common criteria used to evaluate the relevance of
research topics (18;24;25;28). Other aspects that are usu-
ally considered but which are more difficult to quantify in-
clude the existence of social inequalities in health, translation
of new knowledge into clinical practice, and social returns
from the research investment (8;19). Although it is agreed
that explicit criteria should be used to prioritize funding, no
standard method is currently used (20). Consensus strategies
(2;22;26), qualitative methods (5–7;33), and group (23) or
consultation techniques with key stakeholders (10;17;), as
well as economic evaluations of the usefulness of the infor-
mation generated by the research (9), have all been used (16).
Catalonia, an Autonomous Community in northeastern
Spain, has held a biennial call for clinical and health services
research since 1996. The purpose of the call is to finance the
generation and synthesis of evidence aiming at improving the
quality and outcomes of healthcare by providing more and
better information to support decision-making. The call is
primarily financed by the Catalan Health Service, and com-
missioned by the Catalan Agency for Health Technology
Assessment and Research (CAHTA). To identify research
needs, a “call-for-research-topics” is publicly announced to
healthcare stakeholders. The topics received are then priori-
tized by a group of experts using the relevance criteria estab-
lished by the IOM Committee on Priorities for Assessment
and Reassessment of Health Care Technologies (13). Crite-
ria weights are based on an adapted version method carried
out by the Service of Health Technology Assessment of the
Basque Country (OSTEBA) (1). Prioritized research topics
are then included in the final call for projects. Project propos-
als are evaluated in terms of methodology and the research
team’s experience using a standard peer-review system
(Figure 1).
After a decade of experience, the CAHTA decided to
review the “call-for-research-topics” process and evaluate its
own formal prioritizing instrument. The objectives of this
study were to (i) identify new criteria for priority-setting
in the call for clinical and health services research topics;
(ii) develop a composite priority score; and (iii) evaluate
the reliability and validity of the final priority score. After
being adapted, the new method should be more appropriate
to assess topics in a broader area, such as clinical and health
services research, than the original one designed for health
technology assessment.
METHODS
Design
The study was carried out within the CAHTA’s 2006 call
for research topics, which is described in detail elsewhere
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Figure 1. Identification of needs and priority setting during
the call for clinical and health services research by the Catalan
Agency for Health Technology Assessment and Research
(CAHTA).
(29). A three-round expert consensus technique was added
to the usual procedure to identify relevant priority-setting
criteria and their relative weights. The metric properties of
the instrument (final priority score) were evaluated by ex-
perts, who reviewed the topic proposals using a peer-review
method, with a subset reviewed twice by the same reviewer
(retest, in the third round) 3 months later.
Consensus on Priority-Setting Criteria
A modified Delphi technique was used to develop consen-
sus regarding the criteria to be used in priority-setting of
research topics and their relative importance. Participants
were CAHTA’s collaborators from healthcare services and
universities, and CAHTA staff. The first consultation round
included the original seven IOM criteria together with three
additional criteria identified through a review of the literature
and the minutes of previous CAHTA Scientific Committee
meetings. Experts were also asked whether they thought fur-
ther criteria should be included. The second round included
the previous criteria plus those proposed in the first round.
In this round, experts were requested to evaluate (“totally in
agreement,” “in agreement,” “in disagreement,” “totally in
disagreement”) the need to include each of the criteria in the
prioritization system. As recommended (30), an 80 percent
consensus threshold was used to determine whether a crite-
rion should be included or excluded in the new instrument.
Experts were also invited to identify the criterion they con-
sidered the most important (rank = 1) and the criterion they
considered the least important (rank = 11). The sum, means,
and standard deviations of importance ranks were calculated.
Weighting of Criteria
During the third round, experts were asked to give a weight
to each criterion, from 1 (minimum) to 5 (maximum), taking
the criterion previously considered as the least important as
reference (weight = 1). Weights for each criterion were esti-
mated through three statistical methods. The first, calculating
the arithmetic mean. The second, by using the slope from a
linear regression between the arithmetic mean of the weight
and the rank order value of the criterion’s importance. The
third, a further linear regression which took into account the
variability of the scores given to each criterion. In the latter,
the reference criterion was given the same value and a min-
imal variance of 0.05 (instead of 0) in all cases. The scores
resulting from the application of the three methods were
compared with those obtained by applying the IOM weights
through analysis of correlation (Spearman’s coefficient) and
concordance (Kappa’s statistics). In these analyses, topics
were categorized by score quintiles.
Assessment of the Final Priority Score
The same experts evaluate topics proposed in response to the
2006 CAHTA research call applying the final consensus set
of criteria (each one with a Likert-type scale choice: 1, the
lowest value, to 5, the highest value). The final priority score
was calculated using the weights obtained through the three
different methods described earlier as the sum of products
between the score given by the reviewer and the weight of
the criterion. Reliability and validity was evaluated for the
three weighting systems.
The reliability of the priority score (30) was assessed by
examining internal consistency (Cronbach’s α), test–retest
stability (Pearson’s correlation coefficient; CC), and inter-
rater agreement assuming randomized effects (interclass cor-
relation coefficient; ICC), since two experts evaluated each
proposal, as usual. A value of >0.70 was considered satis-
factory for all of the reliability indicators. The number of
topics to re-evaluate for test–retest reliability was set at 146
assuming a 10 percent standard deviation over the score and
a detectable difference of ≥3 points with an alpha risk of
5 percent and a beta risk of 10 percent in a bilateral con-
trast, and 20 percent loss to follow-up. Test–retest reliability
was analyzed using scores for the eight criteria that had two
assessments from the same expert.
INTL. J. OF TECHNOLOGY ASSESSMENT IN HEALTH CARE 26:2, 2010 219
Berra et al.
Construct validity of the new instrument was assessed
by correlating the final score with the global assessment of
each proposal’s priority level, which experts had been asked
to evaluate using a four-category scale (“very low,” “low,”
“high,” “very high”). The area under the receiver operating
characteristic (ROC) curve resulting from the prediction of
the “very high” category was also estimated.
RESULTS
Description of the experts participating
A total of fifty-one experts were invited, forty-eight of whom
participated in the first round and thirty-three in the third
round. Between 72 and 75 percent of the experts (depending
on the round) were physicians and the remainder belonged
to seven other health-related disciplines. Between 40 and 45
percent were CAHTA staff and the remainder were external
collaborators. The average number of topics evaluated by
each reviewer was 12.2 for CAHTA staff and 6.8 for the
external collaborators.
Priority-Setting Criteria
During the first round of the consensus process, a new cri-
terion was proposed for inclusion concerning “the need for
knowledge on the topic.” In the second round, consensus was
reached (over 80 percent agreement) on the inclusion or ex-
clusion of eight of the criteria (Table 1), two of which were
newly added criteria (“potential for translation into practice”
and “need for knowledge”). One of the criteria (“possibil-
ity of clarifying ethical, legal, or social aspects”) achieved a
high, although formally insufficient level of agreement (77
percent), but was eventually included because it is also used
in the IOM system. It was, however, considered to be the
least important criterion. Criteria regarding the “potential to
change health outcomes” and “burden and importance of dis-
ease” most frequently achieved the highest ranking (mean =
2.40 and 2.89, respectively). The latter criterion also had
one of the lowest levels of dispersion (30 percent). The
two criteria that did not reach a minimum consensus for
inclusion (“financial opportunity” and “political interest”)
always ranked below fifth place in terms of importance (Ta-
ble 1, see minimum values), and also had a low variability in
score. Thus, nine criteria were included in the priority-setting
instrument.
Weight of Priority-Setting Criteria
The calculation of the weights based on mean scores re-
sulted in a gap between the criterion with a weight set at 1
and the remaining criteria (Figure 2). Using weights derived
from the regression analyses reduced this gap. Those ob-
tained by predicting the weight using a linear model, which
included the order of importance were the most harmonious.
The three weighting methods correlated strongly with the
scores obtained using IOM weights (Spearman’s coefficient
>0.90). The Kappa’s statistic for the concordance analysis
using score quintiles was approximately 0.61.
Table 2 presents the weights for all of the criteria in-
cluded, together with those used in the IOM and OSTEBA
priority-setting systems. The range of values obtained is
Table 1. Expert opinion on inclusion and importance of criteria for priority setting: Descriptive analysis
Votes for the least important criteria
Agreement
Priority criteria for inclusion Suma Min.-Max. Mean SD % Variabilityb
Previous criteria
1. Prevalence of the condition or health 91.4 2 1–11 4.14 2.29 46
problem (or use of service)
2. Cost of services to manage the condition 88.5 4 2–11 6.34 2.18 44
3. Variation in use of the service 97.1 2 2–10 5.20 2.11 42
4. Burden and importance of the illness 97.2 0 1–6 2.89 1.49 30
5. Potential to change health outcomes 100.0 1 1–10 2.40 2.40 48
6. Potential to change costs 85.8 9 2–10 7.09 2.13 43
7. Potential to inform ethical, legal, or social issues 77.1 11 1–11 7.83 2.51 50
New criteria considered
8. Financial opportunity 62.9 — 5–11 8.77 1.93 39
9. Potential to translate new knowledge into clinical 97.2 9 1–9 4.40 2.40 48
or health services practice
10. Political interest 31.5 — 7–11 10.40 1.14 23
11. Need for knowledge about the problem 82.9 5 1–11 6.71 2.55 51
Note. The data in boldface represent criteria that reached consensus.
aSum of the times that one criterion was voted as being the least important, excluding those for which there was no consensus to include.
bMaximum value of variability calculated from the score range and standard deviation.
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Table 2. Weights for the priority criteria obtained in this study (in descending order), compared with the
original IOM and OSTEBA weights
Priority criteria CAHTA IOM OSTEBA
Potential to change health outcomes 4.23 2.0 2.55
Burden and importance of the illness 3.92 2.25 2.80
Potential to translate new knowledge into clinical or health services practice 3.62 — —
Prevalence of the condition or health problem (or use of service) 3.31 1.6 2.66
Need for knowledge about the problem 3.01 — —
Variation in use of the service 2.70 1.2 2.94
Potential to change costs 2.40 1.5 1.83
Cost of managing the condition 2.09 1.5 1.00
Potential to inform ethical, legal, or social issues 1.78 1.0 2.22
Note. The data in boldface represent the highest weight within each method.
CAHTA, weights for the Catalan Agency for Health Technology Assessment and Research method; IOM, weights for the Institute of
Medicine method; OSTEBA, weights for the Basque Country Health Technology Assessment Service method.
Figure 2. Criteria weights obtained using three different methods.
greater than that obtained in the other two methods, with “po-
tential to change health outcomes” being assigned a weight
which was more than twice that of the criterion considered
least important. The order of the criteria was also different;
the criterion with the highest weight in the IOM method
(“burden of illness”) was here ranked in second place, and
the criterion with the highest weight in the OSTEBA method
(“variations in use”) ranked sixth in the CAHTA system.
Final Priority Score
In the first appraisal of topic proposals, 398 assessments of
199 topics were obtained from forty-eight reviewers. In the
second appraisal (third Delphi round), 113 assessments of
68 topics (74.3 percent of the 152 expected) were obtained
from thirty-five reviewers. A total of forty-six topics were
assessed twice by the same reviewer (test–retest). The final
set of nine criteria showed a sufficiently high internal con-
sistency for measuring priority (Cronbach’s α = 0.75) and
omitting criteria did not significantly affect the alpha value.
The final priority score was slightly lower (−0.40) in the sec-
ond appraisal (p = .297), with a test–retest correlation (CC)
of 0.66. The inter–rater agreement between evaluators was
high (ICC = 0.79). The correlation between the final score
for each topic and the level of priority assigned overall by
experts (construct validity) was moderate (CC = 0.36). The
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area under the ROC curve, which was used as a measure of
the accuracy of predicting a “very high priority proposal,”
was 0.66.
DISCUSSION
The use of sound and explicit criteria to prioritize between
research topics is important for any research funding agency.
In this study, we identified and weighted a set of relevant
criteria for prioritizing clinical and health services research
topics. The priority system proposed is initially based on
the method used by the IOM for setting priorities for the
assessment of healthcare technologies. Two new criteria were
added and different weights reached through a consensus
process which included a variety of experts from different
health science disciplines. The final priority score generated
by the instrument demonstrated satisfactory reliability and
preliminary evidence of validity.
The resulting priority system retains the condition-level
criteria (prevalence, burden of illness, cost, and variability)
that are present in almost any method for prioritizing either
synthesis or generation of evidence and, in addition to main-
taining priority topic-level criteria related to potential im-
pact, adds criteria to the latter level (need for knowledge, and
translation of knowledge into clinical practice) that have been
somehow also recommended for prioritizing effectiveness re-
search (21). Thus, changes made in the method help to extend
its usefulness from the health technology assessment field to
broader areas of clinical and health services research, which
can make a valuable contribution to set a research-led and
evidence-based healthcare policy, as already recognized in
several countries (3;8;11;21;22). The two new criteria (need
for scientific knowledge on a topic, and potential for transla-
tion of new knowledge into practice) may make the system
more relevant to emerging problems and new situations, as
well as helping to reduce gaps in knowledge. They reinforce
the recommendation of taking into account the current state
of evidence for designing new research (4), together with
answering questions relevant to clinical and health policy
decision makers (32). This, in turn, can potentially accel-
erate the impact of scientific advances by getting research
into practice through evidence-based decision making (11).
Likewise, the criterion related to the potential impact of re-
search on health outcomes was assigned the greatest weight
in the present study, compared with burden of disease (13)
or the variability in medical practice (1) in the other studies.
Although this difference could in part be due to differences
between the studies, such as the availability of current and
reliable data on the topics assessed (as recommended by the
IOM) or the characteristics of the experts involved, these
results may also reflect society’s changing priorities, par-
ticularly given the increasing speed with which knowledge
is produced and technological innovations occur, and their
relevance in current biomedical research (34).
This method of quantitative evaluation showed accept-
able reliability. The good internal consistency and the pre-
liminary predictive validity observed here indicate a coherent
measurement system with a good capacity to discriminate be-
tween proposals on the basis of their priority levels. A weak-
ness concerning the reliability analysis was that the retest
measure was not available for one of the criteria, as it was
suggested in the first Delphi round and included in the second
round questionnaire. We were not able to extend the work
with more rounds, but we believe that similar results would
be obtained in a new concordance analysis. The agreement
reached from two peer-review evaluations is moderate. Re-
sults might improve if criteria scoring was categorized using
exact values (e.g. for the prevalence criterion the score of
“1” may mean less than 5 percent, the score of “2” up to
15 percent, etc) as in The Netherlands (27) and partially in
the United States (13), instead of scoring through a qualita-
tive Likert scale (e.g., where the expert decides whether 15
percent of prevalence should be assigned a score of “2” or a
different score).
The concept of priority measured by the instrument was
derived from the opinion of policy makers and experts incor-
porated in the IOM recommendations (13), as well as from
Catalan healthcare stakeholders through a consensus tech-
nique. The score obtained with the tool correlated moderately
with the global assessment of priority that reviewers gave to
each topic, providing preliminary evidence of validity. Al-
though experts participating in the consensus came from a
wide range of health science disciplines, a limitation of this
method is that patients were not represented, in contrast with
some other priority setting initiatives (5;33). The validity of
the priority score could be further evaluated through inves-
tigation of the long-term benefits of the prioritized research
or by a controlled experiment in which a subset of topics are
prioritized by appraisers with and without the prioritization
tool. It would also be interesting to investigate whether and
how use of the system actually impacts on health needs, on
effectiveness, the safety, and quality of clinical practice, or
even on the efficiency and equity of the health system.
POLICY IMPLICATIONS
This work contributes to the increasing debate about strate-
gies for setting research priorities. Despite the limitations
mentioned above, the CAHTA method has several advan-
tages, including the use of updated criteria and weights and
the fact that it is a relatively agile, low-cost, participatory pro-
cess that allows for priority-setting over a much wider range
of topics. Its reliability and validity have also been demon-
strated. The results will be applied in future prioritization
procedures in Catalonia in the hope of improving the rele-
vance and impact of the topics which are funded. Although
this research priority instrument was developed in a regional
context, it might well be applicable to other countries.
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